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ABSTRACT OF THE DISSERTATION
The Effects of a Novel Therapeutic Intervention in Diabetic Peripheral
Neuropathy Patients
by
Adel M. Alshahrani
Doctor of Since, Graduate Program in Physical Therapy
Loma Linda University, September 2015
Dr. Eric Johnson, Chairperson

Diabetes mellitus (DM) is a common disorder affecting individuals in the United
States and in the world. The prevalence of DM has increased noticeably over the last
three decades with an estimated 380 million people currently diagnosed with this disease.
DM is associated with numerous systemic complications that affect the retina, heart,
brain, kidneys, and nerves. The most common complication of DM is diabetic peripheral
neuropathy. Diabetic peripheral neuropathy causes reduced sensation, reflexes,
proprioception, and strength in lower limbs that leads to balance problems. Various
manual therapy techniques have not approached a pilot study for the efficacy of a manual
therapy technique to evaluate symptom alleviation in patients with diabetic peripheral
neuropathy in order to improve balance.
The purpose of this study is to look at the impact of a novel intervention called
Intraneual facilitation (INF) on objective static, objective dynamic, subjective balance
measures, and a peripheral neuropathy scale in patients with Diabetic Peripheral
Neuropathy (DPN).
Balance will be assessed using VSR Computerized Dynamic Posturography
Sensory Organization Test (SOT, objective static balance measure), VSR Computerized
Dynamic Posturography Limits of Stability (LOS, objective dynamic balance measure),
xi

and Activities-Specific Confidence in Balance Scale (ABC, subjective balance measure)
and neuropathy will be assessed using modified total neuropathy scale (mTNS).
Evaluation will be conducted at baseline (pre intervention) and (post intervention). The
results of this study showed hat subjects showed significant improvement in the SOT, one
component in the LOS (movement velocity, MVL), and mTNS (P < .05).
In conclusion, intraneural facilitation improved objective balance measures and
neuropathy symptoms in patients with diabetic peripheral neuropathy. Further study is
needed to determine long-term benefits of this intervention.
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CHAPTER ONE
INTRODUCTION AND REVIEW OF THE LITERATURE

Diabetes Epidemiology
Diabetes has assumed epidemic proportions in the United States (US), with 9% of
the population having the disease. [1]. According to the American Diabetes Association
(ADA), the cost of diagnosed diabetes in the US for the year 2012 was $245 billion,
signifying a 41% increase from $174 billion in 2007 [2]. The bulk of diabetes spending is
attributed to direct medical costs including: inpatient care, prescription medications,
diabetes supplies and anti-diabetic agents, physician office visits, and residential facility
stays [2]. A person with diabetes is likely to spend $7,900 out of pocket in diabetesrelated treatment[2]. This cost is projected to be higher since diabetes increases one’s risk
for cardiovascular diseases and ocular, renal, and neural complications. [3].

Diabetic Neuropathy Epidemiology
The global prevalence of diabetes has increased dramatically in the last three
decades. It is estimated that nearly 380 million people worldwide live with diabetes
mellitus[1]. The most common symptomatic complication of diabetes mellitus is diabetic
neuropathy. Fifty percent of patients with diabetes have neuropathy [4]. The diabetic
peripheral neuropathy (DPN) is a heterogeneous condition that affects different parts of
the body. The chronic sensorimotor distal symmetric polyneuropathy (DSPN) is the most
common type of peripheral neuropathy in diabetic patients [5]. DPN is known to cause
deterioration of the nervous system in the lower limb, which might have a negative
impact on the sensory system [6, 7]. Owing to the lack of true proprioceptive
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information, patients with DPN are more likely to lose balance during static and dynamic
conditions [7-12]. This can lead to an impairment in physical function as a result of
reduced standing and walking activities, usually because the patient is afraid of falling
[13].

Physiological Effects of Diabetic Peripheral Neuropathy
Due to chronic hyperglycemia, normal cellular communication is weakend,
initiating a signaling cascade through the production of protein kinase C and advanced
glycation end products, leading to potential nerve damage. Nerve damage occurs as a
result poor nerve perfusion and endoneural hypoxia caused by reduced capillary blood
flow due to thickening of the axons. [14]. The first pathological change in microvascular
disease is vasoconstriction. This condition results from the thickening of the capillary
basement membrane and hyperplasia, and subsequent decrease in blood flow to the
endothelial cells leading to neural hypoxia. Consequently, patients with DPN demonstrate
delayed reflex responses when their limbs are positioned in various ways due to limited
blood flow to the [15]. These physiological occurrences show that DPN patients are more
likely to demonstrate balance problems and are at a higher risk of falling [16].

Balance and Diabetic Peripheral Neuropathy
Postural stability and balance are coordinated by the central nervous system
through the integration of three systems, visual, vestibular, and somatosensory [17]. An
anomaly on anyone of these systems has a potentially disastrous impact on balance. For
patients with DPN, postural instability and loss of balance is normally as a result of
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discrepancies in the somatosensory system [6, 7]. Due to lack of true proprioceptive
information, patients with DPN are more susceptible to balance loss during static and
dynamic conditions [7-12]. This can lead to impairment in physical function caused by
less standing and walking, usually because the patients fears they may fall [13, 18].
Numerous studies show that patients with DPN have lower balance abilities according to
balance indices [9, 12, 16, 19-23].

Intervention for Diabetic Peripheral Neuropathy in Physical Therapy
Treatment for DPN takes on many forms, and prevention of complications can be
done through excellent blood glucose control. Whereas there are many pharmacological
interventions for DPN symptoms, physical therapy interventions can play an important
role in the management of DPN. It is possible to restore balance by restoring the health of
the neurons, sensory integration, and compensatory strategies. Management of DPN in
physical therapy ranges from using strength exercises and stretching modalities, orthotic
devices, and assistive devices, or the combination of two or more of these interventions
[13].
Numerous studies have been conducted on patients with diabetic peripheral
neuropathy and balance problems. In these studies, physical therapy management ranged
from modalities, exercises, stretching, and assistive device. In one such study, Leonard et
al, [24] divided patients with DPN into two groups. One group used Monochromatic
Infrared Energy (MIRE) and the other group used sham treatment to one leg. Subjects
were then asked questions about balance and perception of falls risk. The investigators
found decreased perceptions of falls risk in both groups. Also, Kochman et al, [25]
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studied the use of MIRE plus strengthening, stretching, and balance exercises on patients
with DPN to improve balance. They found an improvement in Tinetti balance measure
and a reduction in number of falls. Elsewhere, Powell et al, also found a reduction in
number of falls and improvement in fear of falling in a retrospective study of patients
with DPN treated with MIRE unit for home use [26]. Pripalta et al, [27] divided his
subjects into two groups. One group received vibration insoles that delivered sub-sensory
vibration and the other group with no vibration insoles. They found reduction in all sway
parameters. Richardson et al, [28] divided the subjects into two groups. One group
received open and closed chain ankle strengthening, wall slides, and single-leg stance and
the other group neck flexion and scapular stabilization exercises. They found significant
improvement on tandem stance, single-leg stance, and functional reach. Ashton-Miller et
al, [29] divided the subjects into two groups. One group used single-end cane and the
other group with no cane. They found reduction in failure fail. Mueller et al, [30] studied
weight bearing exercises versus non weight bearing exercises on patients with DPN. The
weight-bearing group showed significance improvement over the non-weight bearing
group in the 6-minute walk distance and daily step counts.

Intraneural Facilitation (INF)
The INF intervention is a manual physical therapy approach that was invented and
developed by physical therapists at Loma Linda University’s east campus rehabilitation
services. The intervention is used together with anecdotal evidence in reducing peripheral
neuropathy symptoms. The main concept of this approach is the use of two holds. The
first hold is called facilitation hold. It entails putting the joint in the other side of the
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targeted limb in full loose packed position. For instance, we would put the ankle joint in
full planter flexion and inversion and this position would be sustained during the whole
session with a stretch strap. We hypothesized that with the joint in this position, the nerve
will move more than the artery because the artery has more elastin in it. In this casethe
nerve is more mobile. The nerve would have more excursions that would stretch the
nutrient vessels that are clustered in the joint. the nutrient vessels would have larger
opening than the cardiovascular system and more consistent opening [31]. The nutrient
vessels in the epineurium will bifurcate in two directions up and down. When they reach
the perineum, they will feed the neural connective tissue and we will have more
consistent blood flow in the outside of nerves system. By putting consistent pressure in
these nutrient vessels, the blood flow will be biased from the cardiovascular system into
the nerves and it continues process.
Now, the second hold is a stretch, which slightly stretches the perineurium,
potentially unweighting the pressure on the transperineurial vessels allowing circulation
to proceed from the epineurial arterioles to the endoneurial capillaries. An example
would be a hamstring stretch that would put more blood supply into the sciatic nerve. The
purpose of the second hold is to open the perinirium that is the tough middle layer of the
neural connective tissue. When the opening happens, we propose this would decompress
and allow more blood supply from the outside into the inner part of nerve facicle then
into endoneurial capillaries. When the endoneurial capillaries gets more consistent blood
flow, it can produce nitric oxide by compressing the pressurized red blood cells into the
inflamed capillaries which will lead to vasodilation of endoneurial capillaries [32].
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Sensory Organization Test (SOT)
This tool can help researchers to obtain objective scores for static balance. It can
assess the ability to utilize vision, somatosensory, and vestibular systems to maintain
balance. The NeuroCom® Smart Balance Master system computerized dynamic
posturography (CDP) was utilized in the present study. This apparatus consists of two
force plates. The force plates can be pitched up and down as well as in the anteriorposterior direction. For this test, the patient wore a safety harness while two researchers
surrounded the patient to minimize the risk of falling. The researchers asked patient to
stand upright on the center of the force plates in a standardized position with shoes on.
The patient faced a monitor enclosed by visual surround on three sides.
The test itself consists of six conditions and each condition has three 20-second
trials. It identifies abnormalities in three sensory systems that help in postural control:
somatosensory, visual, and vestibular. In condition 1, the patient is required to stand still
and all sensory information is available. In condition 2, the patient is required to stand
still with eyes closed. In condition 3, the surround moves as the patient moves on the
force plates. In condition 4, the force plates move as the patient moves. In condition 5,
the patient is required to close their eyes and the force plates move as the patient moves.
In condition 6, the surround and force plates move as the patient moves. We took the
composite equilibrium score and considered static balance score.
The equilibrium score represents the average center of gravity sway for each trial in the
six conditions. The normal limit of the Anterior/Posterior (AP) sway angle is 12.5
degrees. We can obtain the equilibrium score from the following equation, ([12.5deg (the taMAX – the taMIN)] / 12.5deg) * 100. The total score of this test is 100. Subjects
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with little AP sway will acquire scores close to 100, whereas subjects with enormous AP
sway will receive scores near zero. In the screen after finishing the test, the green bars
represents the range within normal limits and red the range outside the normal limits.

Limits of Stability (LOS)
This tool can help researchers to obtain objective score for dynamic balance. It
measures the maximum distance the COG can be moved while maintaining postural
stability. The NeuroCom® Smart Balance Master system computerized dynamic
posturography (CDP) was utilized for this purpose. This apparatus consists of two force
plates. The force plates can be pitched up and down as well as in anterior-posterior
direction at a frequency of 100 Hz. During this test the patient wore safety harness and
two researchers were surrounding the patient to minimize the risk of falling. The
researchers asked subjects to stand upright on the center of the force plates in a
standardized position with shoes on. The subject faced a monitor enclosed by visual
surround on three sides.
For it to quantify control of the center of gravity (COG), the patient is required to
voluntarily sway to eight directions without losing their balance spaced at 45 degrees
intervals, as represented in computer screen in front of the subject. These eight directions
include pure forward, forward-right, pure right, back-right, pure back, back-left, pure left,
and forward-left. The LOS report includes reaction time (RT, the time in seconds
between the command and the movement of the subject), movement velocity (MVL, the
average speed of COG in degrees per seconds), endpoint excursion (EPE, the distance
achieved toward a target on the first movement), maximum excursion (MXE, maximum
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distance achieved), and directional control (DCL, the difference of amount of movement
towards the target to away from the target). We took the composite scores of RT, MVL,
EPE, MXE, and DCL from the eight directions. In the screen after finishing the test, the
green bars represents the range within normal limits and red the range outside the normal
limits.

Activities-Specific Balance Confidence Scale (ABC)
Activities-Specific Balance Confidence Scale (ABC) [33], is a subjective
measure of confidence in performing several activities without losing balance or
suffering a sense of wobbliness. It is a 16-item self-report measure in which subjects rate
their balance confidence for performing activities. Each item ranges from 0 – 100. Score
of zero implies falling and a score of 100 implies patient’s confidence of stability. We
can get the total score of this scale by adding all items together then dividing by 16. The
equation for the ABC is: (overall score of the 16 items /16) * 100. Studies showed that
the ABC has excellent test-retest reliability (r=0.92, p<0.001) [33].

Modified Total Neuropathy Scale (mTNS)
The San Antonio Consensus meeting recommended assessing the peripheral
neuropathy with combining quantitative vibrations threshold, quantitative touch
threshold, nerve conduction, and patients’ report [34].The total neuropathy scale was first
used 1994 [35]. It demonstrated its reliability (interrater reliability, .94; intrarater reliability, .97) [36] although it included nerve conduction studies, which makes it hard to
use in a clinical setting. Another version called modified Total neuropathy Scale (mTNS)
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developed in 2006, does not include nerve conduction studies [37]. The mTNS is scored
from 0 to 24 with each neuropathy rated from 0 to 4 (0 being normal, 4 being severe
neuropathy). The higher the score, the more severe the neuropathy. The mTNS severity
levels are 3: 0-8 (mild), 9-16 (moderate) and 17-24 (severe). Usually the clinical testing
for the mTNS includes muscle strength, vibration sense, pin level, and reflexes [38].
Wampler et al [37], found positive correlations between the mTNS and the TNS (r =
0.99; P < 0.001).

Summary
Diabetes continues to be a major health burden in the US. In addition to the cost of
treatment, diabetes also affects quality of life through debilitating conditions such as
diabetic retinopathy, cardiomyopathy, and neuropathy [5, 39]. Of these complications, the
diabetic peripheral neuropathy (DPN) whichaffects peripheral nerves and circulation, can
lead to impairment in balance [9, 12, 16]. Patients with DPN are more likely to lose balance
during static and dynamic conditions as a result of impaired proprioceptive input. [7-12].
This often results in impairment in physical function caused by limited activity since
patients stand and walk less for fear of falling [13, 18]. The current study was a clinical
trial approach to determine the effectiveness of INF on objective static measures, dynamic
balance measures, and a subjective balance measure. We used quantitative posturography
balance measures given their objectivity and utilization in many previous studies [40-43].
We also measured the effect of INF on a neuropathy scale.
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Abstract
Objective: To determine the effect of a novel therapeutic intervention called
intraneural facilitation (INF) on balance measures and a neuropathy scale in patients with
diabetic peripheral neuropathy.
Design: Prospective pre- and post-test, single group clinical trial.
Setting: Outpatient physical therapy clinic.
Participants: Thirteen patients with diabetic peripheral neuropathy.
Intervention: Subjects received ten sessions of INF.
Main Outcome Measures: The modified total neuropathy scale (mTNS), the
NeuroCom® Smart Balance Master system computerized dynamic posturography (CDP)
that includes the sensory organization test (SOT) and the limits of stability (LOS), and
the activities-specific balance and confidence (ABC) scale.
Results: Subjects in this study showed significant improvement in the mTNS,
SOT, and one component in the LOS (movement velocity, MVL). There were no
significant differences in the ABC or in 4 components of the LOS, which were reaction
time (RT), endpoint excursion (EPE), maximum excursion (MXE), and directional
control (DCL).
Conclusion: Intraneural facilitation improved objective balance measures and
neuropathy symptoms in patients with diabetic peripheral neuropathy. Further study is
needed to determine long-term benefits of this intervention.
Keywords: Balance, Postural; Diabetes Mellitus, Diabetic Neuropathies, Manual
Therapies.
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Abbreviations
INF

Intraneural Facilitation

DPN

Diabetic Peripheral Neuropathy

CDP

Computerized Dynamic Posturography

SOT

Sensory Organization Test

LOS

Limits of Stability

RT

Reaction Time

EPE

Endpoint Excursion
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Maximum Excursion

DCL

Directional Control

ABC

Activities-Specific Balance Confidence Scale

DSPN

Sensorimotor Distal Symmetric Polyneuropathy

mTNS

Modified Total Neuropathy Scale

COG

Center of Gravity

DM

Diabetes Mellitus
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Introduction
Diabetes mellitus (DM) is a common disorder affecting individuals in the United
States and in the world [1]. The prevalence of DM has increased noticeably over the last
three decades with an estimated 380 million people currently diagnosed with this disease
[1]. DM is associated with numerous systemic complications that effect the retina, heart,
brain, kidneys, and nerves [5, 39].
The most common symptomatic complication of DM is diabetic polyneuropathy
(DPN), estimated to occur in 50 percent of patients with DM [4]. Despite therapeutic
advances of diabetes care over the past decade, there are few known interventions that
appropriately address the progression and treatment of DPN [44]. DPN can occur in
many forms but most commonly presents as a painless sensorimotor distal symmetric
polyneuropathy (DSPN) [5].
Diabetic DSPN causes deterioration of the peripheral nervous system in a lengthdependent fashion and can negatively impact the sensory system [6, 7]. Impaired
proprioceptive input renders these patients more susceptible to loss of balance during
static and dynamic conditions [7-12]. This can impair physical function by reducing
standing and walking activities as many patient experience fear of falling [13, 18].
The pathogenesis of DPN is multifactorial and mediated by alterations in the
polyol pathway, aldose reductase inhibitors, advanced glycolation products, disordered
biochemistry consequences, essential fatty acids, neurotrophic factors and oxidative
stress. The common pathological endpoint is endoneurial microangiopathy and
subsequent nerve ischemia and hypoxia [14, 45]. As such, DPN patients are more likely
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to develop an array of peripheral nerve disorders, balance problems, and a higher risk of
falling [9-12, 16, 19-23, 45].
The proposed study utilizes an innovative approach termed intraneural facilitation
(INF) in the treatment of diabetic DSPN. This approach aims to bias blood flow into the
neural fascicle, improve endoneurial capillary circulation, and reverse intrafascicular
ischemia. This passive technique includes stretching muscles, mobilizing joints,
tractioning skin, distending visceral structures, and distorting blood vessels to reroute
blood to the ischemic nerves [32]. We sought to determine the effectiveness of INF in
DSPN using validated neuropathy scales, objective static measures, dynamic balance
measures, subjective balance measure, and quantitative posturography balance measures
[40-43].

Methods
This IRB-approved study was conducted at Loma Linda University (LLU), which
is a tertiary teaching hospital with an outpatient physical therapy clinic providing care to
a diverse group of patients. Study subjects were screened from our clinic between
October 2014 and February 2015. Informed consent was obtained and the assessment and
intervention procedures were conducted in our physical therapy area.
Inclusion criteria for this study included:
1. Male and female patients with DPN from 18 to 85 years of age,
2. DSPN form of DPN confirmed by a medical doctor,
3. Ability to hold static balance for a minimum of 5 minutes.
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Potential subjects were excluded if they had co-morbidities such as open wounds, cardiac
disease, or other forms of progressive neurological disease or peripheral polyneuropathy
impacting balance.

Modified Total Neuropathy Scale (mTNS)
The mTNS is scored from 0 to 24 with each neuropathy rated from 0 to 4 (0 being
normal, 4 being severe neuropathy). The mTNS severity levels are divided into 3 levels:
0-8 (mild), 9-16 (moderate) and 17-24 (severe). The clinical testing for the mTNS
includes muscle strength, vibration sense, pin sensation level, and muscle stretch reflexes
[38].

Static and Dynamic Balance Scales
The NeuroCom® Smart Balance Master system computerized dynamic
posturography (CDP) was utilized. This apparatus consists of two force plates that can be
pitched up and down as well as in an anterior-posterior plane. During this test our
subjects wore safety harnesses and supported by two researchers to minimize the risk of
falling. The subjects stood upright on the center of the force plates in a standardized
position. In this machine two tests were utilized:
1. The Sensory Organization Test (SOT) assesses three sensory systems that affect
postural control (visual, somatosensory, and vestibular) (Figure.1A). Six different
conditions are tested consecutively with three 20-second trials: in step 1 the
patient is required to stand still with eyes open (all sensory information available);
in step 2 the patient is required to stand still with their eyes closed; in step 3 the
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surround moves as the patient moves; in step 4 the force plate moves as the
patient moves; in step 5, the patient closes their eyes and the force plates move as
the patient moves; in step 6, the surround and force plate move as the patient
moves. We assessed the composite equilibrium and static balance scores (Figure.
1B). [46-48]
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Figure 1A. Computerized Dynamic Posturography Sensory Organization Test (SOT)
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Figure 1B. Subjects performed six conditions in the SOT. They stood still on a
forceplate with their feet positioned according to a standardized grid and arms by the
side.

18

2. Limits of Stability (LOS) quantifies control of the center of gravity (COG)
(Figure 2A). The patient is required to voluntarily sway to eight directions
without losing their balance (Figure 2B). The LOS report includes reaction time
(RT), movement velocity (MVL), endpoint excursion (EPE), maximum excursion
(MXE), and directional control (DCL). We took the composite scores of RT,
MVL, EPE, MXE, and DCL from the eight directions.
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Figure 2A. Computerized Dynamic Posturography Limits of Stability (LOS)
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Figure 2B. Subjects in LOS went through leaning in eight directions as the arrows
represent it. They stood still on a forceplate with their feet positioned according to a
standardized grid and arms by the side.

21

Activities-Specific Balance Confidence (ABC) Scale
The ABC Scale [33] is a subjective measure of confidence in performing several
activities without losing balance or suffering a sense of wobbliness. It is a 16-item selfreport measure in which subjects rate their balance confidence for performing certain
activities. Each item ranges from 0 – 100. A score of zero implies falling and a score of
100 implies patient’s confidence of stability. The total score of this scale is derived by
adding all items together then dividing by 16.

Data Collection
Pre-treatment assessment included baseline demographic data, the mTNS, SOT &
LOS scores, and the ABC scale.
Post-treatment data was collected for these same measures following 10 sessions
of INF treatment.

Data Management and Analysis
Data Management: Two researchers conducted data management using coding
manuals for all study measures. All study data was initially reviewed to identify missing
values. Methods for missing value adjustment included imputation, list-wise deletion or
case-wise deletion. All modifications were recorded in the data-coding manual for future
missing data analysis.
Data Analysis: data were analyzed using statistical package SPSS for Windows
version 22.0 (SPSS, Inc., Chicago, IL). Means and standard deviations were calculated
for the outcome measures separately for pre-intervention and post-intervention. Paired t-
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test was used to detect significant change in SOT, RT, MVL, EPE, MXE, and DCL
between pre-intervention and post-intervention. Wilcoxon signed was used to compare
differences in DCL and mTNS between pre-intervention and post-intervention. A p of .05
or less was considered significant.

Results
Of 25 subjects screened for our study, 17 met inclusion criteria and were enrolled.
Of these, 13 completed the study (Figure 3). Four subjects did not complete the study:
one developed a foot infection, one had insurance problems that prevented ongoing
therapy, and two elected to exit the study due to time restraints. Subject demographics are
listed in the Table 1.
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Screening of subjects with
Diabetic Peripheral
Neuropathy (N=25)

Subjects did not meet
our inclusion criteria
(N=7)

Meets inclusion criteria and
included in the study (N=17)

Consent form

Pre-Test
SOT *
LOS †
ABC ‡
mTNS §

Intervention
INF ||
(10 visits)
Excluded from the
study (N=4)
Post-Test
SOT
LOS
ABC
mTNS

Figure 3. Subject screening and completion.
* Sensory organization test.
† Limit of stability
‡ Activities of balance confidence
§ Modified total neuropathy scale
|| Intraneural facilitation
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Table 1: Patients’ demographics

Age
Gender

N
13

Minimum Maximum
49
73

25

Mean
65.15

Std.
Deviation Male
7.548
7

Female
6

The mTNS showed significant reduction from pre and post treatment
measurements (p = .001) (Table 2). For changes in SOT, we found a significant increase
from pre- and post-treatment measurements (p = .012) (Table 3). For LOS components,
the MVL showed a significant increase from pre to post-treatment measurements (p =
.023) (Table 4). The remaining measures of RT, DCL, EPE, MXE, and ABC showed a
trend towards improvement but did not show statistically significant differences before or
after INF (Tables 4 & 5).

26

Table 2: Changes in modified total neuropathy scale (mTNS)

mTNS

N
13

Pre
Mean
10.62

Pre SD*
4.37

P value from Wilcoxon signed rank test

* Standard deviation
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Post
Mean
7.77

Post
SD*
4.19

Mean
Difference
-2.85

P value
.001

Table 3: Changes in sensory organization test (SOT)

SOT

N
13

Pre
Mean
53.77

Pre SD*
21.81

P value from paired t-test

* Standard deviation
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Post
Mean
66.00

Post
SD*
14.32

Mean
Difference
12.23

P value
.012

Table 4: Changes in limits of stability (LOS)

RT*
DCL†
EPE‡
MVL§
MXE||

N
13
13
13
13
13

Pre
Mean
0.91
55.44
39.68
1.99
54.31

Pre
SD¶
0.62
32.57
23.61
1.25
31.87

a P value from paired t-test
b P value from Wilcoxon signed rank test
* Reaction time
† Directional control
‡ End point excursion
§ Movement velocity
|| Maximum excursion
¶ Standard deviation
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Post
Mean
0.81
63.15
48.31
3.28
68.46

Post
SD¶
0.36
20.45
17.15
1.26
24.14

Mean
Difference
-0.10
7.71
8.62
1.29
14.15

P value
.544a
0.834b
.334a
.023a
.249a

Table 5: Changes in activities-specific of balance confidence (ABC)

ABC

N
13

Pre
Mean
71.42

Pre SD*
25.78

P value from paired t-test

* Standard deviation
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Post
Mean
78.02

Post
SD*
17.01

Mean
Difference
6.60

P-value
.119

Discussion
The results of our study are consistent with previous reports indicating that
patients with DSPN are more susceptible to falls during static and dynamic conditions
[19, 49, 50]. In addition, our results show that INF can improve neuropathy symptoms as
measured by the mTNS (p = .001), static balance or SOT (p = .012), and dynamic
balance or MVL (p = .023) scores. All other LOS components (RT, DCL, EPE, and
MXE) showed a trend towards post-treatment improvement but were not statistically
significant.
We chose to use the mTNS in our study because it was easy to use and is a valid
tool [37]. The CDP has been used extensively in the literature for different conditions as a
validated tool to measure static and dynamic balance [51-53]. Whitney et al [54], looked
at the relationship between falls history and CDP scores. They found that scores of < 38
increased the likelihood ratio for recognizing repeated fallers in the past 6 months. On
diabetic subjects, Simmons et al [42], measured postural instability in two groups: those
with or without cutaneous sensory discrepancies and a control non-diabetic group. They
found that CDP scores are less for subjects with cutaneous sensory discrepancies so they
are more likely to postural instability. In another study Di Nero et al [55], found that CDP
distinguished between DM subjects with and without peripheral neuropathy.
While many interventions have tried to mitigate the impact of DPN through
exercises, it remains a progressive disease with few effective interventions. There are few
systematic physical therapy approaches that are typically used in treating patients with
DPN. For instance, Kochman et al, [25] studied the use of monochromatic infrared
energy (MIRE) plus strengthening, stretching, and balance exercises on patients with
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DPN to improve balance. They reported improved balance and reduction in number of
falls. Mueller et al [30] investigated weight-bearing exercises versus non-weight bearing
exercises on patients with DPN. The weight-bearing group revealed significant
improvement over the non-weight bearing group.
The effects of therapeutic rehabilitation on balance in patients with DPN have
included modalities [24], combining modalities with exercises [25], exercises [28, 30],
and assistive devices [29]. Ashton-Miller et al [29] divided subjects into two groups. One
group used a single-point cane and the other group did not use a cane. They found a
reduction in failure rate during weight transfer to unipedal stance. Richardson et al [28]
divided the subjects into two groups. One group received open and closed chain ankle
strengthening, wall slides, and single-leg stance and the other group neck flexion and
scapular stabilization exercises. They found significant improvements in tandem stance,
single-leg stance, and functional reach. Mueller et al [30] studied weight bearing
exercises versus non-weight bearing exercises on patients with DPN. The weight bearing
group showed significance improvement over the non-weight bearing group in the 6minute walk distance and daily step counts. Exercises may play an important role on
patients with DPN. On the other hand, exercises usually need weight bearing and
utilization of painful limbs. Also, recent studies highly recommended minimal physical
activity for patients with DPN to prevent adverse events [56, 57]. In order to decrease
pain, parasthesia, and lesions associated with DPN through physical therapy, we should
limit patient participating with exercise activities in order to enhance functional outcomes
[56, 57]. The present study demonstrates decreased neuropathic symptoms and improved
balance using INF. By reducing patient neuropathic symptoms, INF may enhance patient
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participation in therapeutic exercise programs and form a bridge between the inactive
painful diabetic patient and the active non-painful diabetic patient who can exercise.
The INF intervention is a novel manual physical therapy approach with anecdotal
evidence in reducing peripheral neuropathy symptoms. The main concept of INF is the
use of two manual holds. The first hold is called facilitation hold (Figure 4). It includes
putting the contralateral joint in a maximal loose-pack position. For example, the ankle
joint in contralateral side will be in full planter flexion and inversion. This position will
be sustained during the whole session with a stretch strap. We hypothesize that with the
joint in this position the nerve will move further than the artery as the artery has more
elastin. With increased neural excursion in relation to the artery, the nutrient vessels that
are clustered at the joint will be stretched. This stretch may enlarge the opening at the
junction of the artery and bridging nutrient vessel, thus consistently creating a vascular
bias into the neural epineurial capillaries. Theoretically, this creates increased epifasciular
vascular pressure. [31].
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Figure 4. Facilitation hold includes positioning the contralateral ankle joint in a
maximal loose-pack position of plantar flexion and inversion. This position is maintained
throughout the entire session.
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With increased endoneurial edema and a strong perineurium, the pressurized
blood flow may not push through the transperineurial vessels that cross the perineurium
into the endoneurial capillaries. A second hold or mild stretch is necessary to bias the
increased epineurial blood flow past the perineurium into the endoneurial capillaries. This
hold potentially provides an unweighting pressure. The second hold or stretch will also
enable the therapist to bias circulation in the neural structures that appear to be most
affected. For example a hamstring stretch would bias blood flow into the sciatic nerve
microvasculature (Figure 5). Previous studies demonstrated short-term exercise effects on
endoneurial capillaries including stimulating endothelial vasodilation, enhancing
endoneurial blood flow, improving abnormal nerve perfusion, increasing the release of
nitric oxide, and enhancing the concentration of Na/K ATPase [58-62]. We hypothesize
that improvements in the mTNS of our subjects were due to these immediate vascular
changes that occurred in the treated extremities although more research is need to
substantiate this [32].
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Figure 3. Secondary hold. In case of impaired sciatic nerve, a hamstring stretch
bias’s blood flow into the sciatic nerve microvasculature.
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Study limitations
Our study limitations include the potential for bias with mTNS assessment as the
clinician who provided the treatment also assessed the mTNS pre and post intervention.
Other limitations were not having a control or sham group and the small sample size that
does not allow for generalization of our study findings. Moreover, the present study only
measured short-term benefits of the intervention.

Conclusion
This pilot study showed that INF improves static and dynamic balance measures
as well as neuropathy symptoms using validated measures in patients with diabetic
DSPN. Whether the improvements in balance measures noted in the intervention
subjects translate into decreased fall risk in daily life is uncertain. However, given the
minimal risk associated with INF, we believe our results warrant further study of this
technique in patients with diabetic and idiopathic DSPN to establish long-term benefits,
measure the effect of INF on pain measures, and if possible employ a control or sham
group.
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CHAPTER FOUR
DISCUSSION
The prevalence of diabetes has increased noticeably over the last three decades. It
is estimated that 380 million people worldwide live with diabetes mellitus. Diabetes
mellitus is a progressive disease process which can result in numerous health
complications. [1]. It places a significant burden on the healthcare system, not to mention
debilitating conditions associated with it (diabetic retinopathy, cardiomyopathy, and
neuropathy) [5, 39]. Diabetic peripheral neuropathy (DPN) is known to affect peripheral
nerves and circulation and may lead to impaired balance [9, 12, 16]. As a result of
impaired proprioceptive input, patients with DPN are therefore more susceptible to loss
of balance during static and dynamic conditions [7-12]. This may lead to impairment in
physical function due to a reduction in standing and walking activities as many patients
experience fear of falling [13, 18].
The current study was a clinical trial designed to test the effectiveness of
intranueral facilitation (INF) on objective static measures, dynamic balance measures,
and a subjective balance measure. The INF is an innovative approach which aims to bias
blood flow into the neural fascicle improving endoneurial capillary circulation and
reversing intrafascicular ischemia in an attempt to improve neural blood flow. This
passive techniques may involve stretching affected muscles, mobilizing joints, tractioning
skin, distending visceral structures, and distorting blood vessels to reroute blood to the
ischemic nerves [32]. . We used quantitative posturography balance measures given their
objectivity and utilization in many previous studies [40-43].

43

Also, we measured the effect of INF on a neuropathy scale. The INF intervention
is a novel manual physical therapy approach with anecdotal evidence in reducing
peripheral neuropathy symptoms. The main concept of INF is the use of two manual
holds. The first hold is called facilitation hold. It comprises placing the contralateral joint
in a maximal loose-pack position. For example, the ankle joint in contralateral side will
be in full planter flexion and inversion. This position will be sustained during the whole
session with a stretch strap. We hypothesized that with the joint in this position the nerve
will move further than the artery as the artery has more elastin. With increased neural
excursion in relation to the artery, the nutrient vessels that are clustered at the joint would
be stretched. This stretch may enlarge the opening at the junction of the artery and
bridging nutrient vessel, thus consistently creating a vascular bias into the neural
epineurial capillaries. Theoretically, this creates increased epifasciular vascular pressure.
[31].
With increased endoneurial oedema and a strong perineurim, the pressurized
blood flow may not push through the transperienurial vessels that cross the perineurium
into the endoneurial capillaries. A second hold or mild stretch is necessary to bias the
increased epineurial blood flow past the perineurium into the endoneurial capillaires. This
hold potentially provides an unweighting pressure. The second hold or stretch will also
enable the therapist to bias circulation in the neural structures that appear to be most
affected. For example a hamstring stretch would bias blood flow into the sciatic nerve
microvasculature. When the endoneurial capillaries gets more consistent blood flow, it
produces nitric oxide by compressing of the pressurized red blood cells into the inflamed
capillaries which will lead to vasodilation of endoneurial capillaries [32].
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The results of this study are consistent with those of previous studies indicating
that patients with DPN are more susceptible to falls during static and dynamic conditions
[19, 49, 50]. The current study was conducted to determine the effect of a novel
therapeutic approach, INF, for patients with DPN. Our results suggest that INF can
improve static and dynamic balance, and neuropathy symptoms including reduced muscle
strength, vibration sense, pin level (sharp/dull), and reflexes in patients with DPN.
Subjects in this study increased their composite equilibrium score between preintervention and post-intervention by 22.47% (p = .012). In the LOS components, RT,
DCL, EPE, and MXE also improved but were not statistically significant. However,
MVL component in LOS showed significant difference p = .023. The ABC was not
significantly improved. This may be the result of a ceiling effect which has been
previously reported in the literature [63].
There was a significant reduction 44.17% (p = .001) in the mTNS. We chose to
use the mTNS in our study because it was easy to use and is a valid tool [37]. The San
Antonio Consensus meeting recommended assessing peripheral neuropathy by combining
quantitative vibrations threshold, quantitative touch threshold, nerve conduction, and
patients’ report [34]. The TNS is a reliable tool used to assess peripheral neuropathy in
diabetic patients[36]. However, it is an expensive and time-consuming tool. The mTNS
was proposed as an alternative for the TNS in the clinical settings and it showed its
effectiveness. Wampler et al [37], found positive correlations between the mTNS and the
TNS (r = 0.99; p < .001).
The effects of therapeutic rehabilitation on balance in patients with DPN have
been previously reported in the literature. These studies include modalities [24],
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combining modalities with exercises [25], exercises [28, 30], and assistive devices [29].
Ashton-Miller et al [29] divided subjects into two groups. One group used a single-point
cane and the other group did not use a cane. They found a reduction in failure rate during
weight transfer to unipedal stance.
Richardson et al. [28] divided the subjects into two groups. One group received
open and closed chain ankle strengthening, wall slides, and single-leg stance and the
other group neck flexion and scapular stabilization exercises. They found significant
improvements in tandem stance, single-leg stance, and functional reach. Mueller et al.
[30] studied weight-bearing exercises versus non weight-bearing exercises on patients
with DPN. The weight-bearing group showed significance improvement over the nonweight bearing group in the 6-minute walk distance and daily step counts.
Exercises might play an important role on patients with DPN. On the other hand,
exercises usually need weight-bearing and utilization of painful limbs. Also, recent
studies highly recommended minimal physical activity for patients with DPN to prevent
adverse events [56, 57]. In order to decrease pain, paresthesia, and lesions associated with
DPN through physical therapy, we should limit patient participation in exercise activities
in order to enhance functional outcomes [56, 57]. The present study demonstrates
decreased neuropathic symptoms and improved balance using INF. By reducing patient
neuropathic symptoms, INF may decrease patience towards participating in a therapeutic
exercise program. Thus, forming a bridge between the inactive painful diabetic patient
and the active non-painful diabetic patient who can exercise.
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This study was limited by the potential for bias with mTNS assessment since the
clinician who provided the treatment also assessed the mTNS pre and post intervention.
Our study’s greatest limitation was not having a control group to compare our results
with. Also, the small sample size does not allow for generalization of our study findings.
Furthermore, the present study only measured short-term benefits of the intervention.
Future studies should look at long-term benefits of this intervention with a larger sample
size.
In conclusion, this pilot study showed that INF improves static and dynamic
balance measures as well as neuropathy symptoms using validated measures in patients
with diabetic DSPN. Whether the improvements in balance measures noted in the
intervention subjects translate into decreased fall risk in daily life is uncertain. However,
given the minimal risk associated with INF, we believe our results warrant further study
of this technique in patients with diabetic and idiopathic DSPN to establish long-term
benefits, measure the effect of INF on pain measures, and if possible employ a control or
sham group.
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APPENDIX A
ACTIVITIES-SPECIFIC BALANCE CONFIDENCE (ABC) SCALE

For each of the following activities, please indicate your level of self-confidence
by choosing a corresponding number from the following rating scale:
0%

10

20

30

40

50

60

70

No confidence

80

90

100%

Completely confident

“How confident are you that you will not lose your balance or become unsteady when
you…
1.

…walk around the house? ____%

2.

…walk up or down stairs? ____%

3.

…bend over and pick up a slipper from the front of a closet floor ____%

4.

…reach for a small can off a shelf at eye level? ____%

5.

…stand on your tiptoes and reach for something above your head? ____%

6.

…stand on a chair and reach for something? ____%

7.

…sweep the floor? ____%

8.

…walk outside the house to a car parked in the driveway? ____%

9.

…get into or out of a car? ____%

10.

…walk across a parking lot to the mall? ____%

11.

…walk up or down a ramp? ____%

12.

…walk in a crowded mall where people rapidly walk past you? ____%

13.

…are bumped into by people as you walk through the mall?____%

14.

… step onto or off an escalator while you are holding onto a railing? ____%
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15.

… step onto or off an escalator while holding onto parcels such that you
cannot hold onto the railing? ____%

16.

…walk outside on icy sidewalks? ____%
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APPENDIX B
RESEARCH FLYER
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APPENDIX C
INFORMED CONSENT

Title:

The effect of intra-neural facilitation on balance in patients with
diabetic peripheral neuropathy

Sponsor :

Department of Physical Therapy, Loma Linda
University

Principal
investigaor:

Eric Glenn Johnson, DSc, PT, MS-HPEd, NCS
Professor, Physical Therapy Department
Loma Linda University, Loma Linda CA
School of Allied Health Professions
Nichol Hall Room #A-712
Phone: (909) 558-4632 Extension 47471
Fax: (909) 558-0459
Email Address: ejohnson@llu.edu
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1. Why is this study being done?
The purpose of the study is to determine the effect of Intra-Neural Facilitation (INF) on
balance.
INF is a Physical Therapy treatment approach that is prescribed by physicians for patients
with diabetic peripheral neuropathy. There have been no research publications describing
the effects of INF in patients with diabetic peripheral neuropathy.
You are invited to participate in this research study because you are an adult between the
ages of 18-85 years with Diabetes (Type 1 or 2) diagnosed by a physician, have distal
symmetrical lower extremity symptoms for greater than 3 months including impaired
sensation and have been referred to physical therapy for intraneural facilitation (INF).

2. How many people will take part in this stduy?
Approximately 40 subjects will participate in this study.

3. How long will the study go on?
Your participation in this study will include 60 minutes on the first day of your Physical
Therapy visit and another 60 minutes after 10 sessions of INF.

4. How will be involved?
Participation in this study involves the following:
Your date of birth, height and weight will be recorded. In addition to the INF that you
were referred by your physician to receive, you will complete a questionnaire on your
balance confidence that will take about 5-10 minutes. We will also measure your standing
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balance with a computerized device that will take about 15-20 minutes. This device has a
stable platform that records your body sway with eyes open then eyes closed. No special
clothing is required. A safety harness will be placed on you and two researchers will be
near you in case you lose your balance. The entire process will take approximately 60
minutes on the first and second days of data collection. All data collection will take place
at your regularly scheduled physical therapy appointment times and location.

5. What are the reasonably foreseeable risks or discomfort I might have?
Participating in this study exposes you to minimal risk because you may lose your
balance during the testing procedures. To prevent falling, you will be wearing a safety
belt and two researchers will be standing beside you at all times. There is also a minimal
risk of breach of confidentiality.

6. Whill there be any beefit to me or others?
Although you will not benefit from this study, the information gathered from the study
may benefit future patients with balance impairments resulting from diabetic peripheral
neuropathy if INF is shown to improve balance.

7. What are my rights as a subject?
Participation in this study is voluntary. Your decision whether or not to participate or
withdraw at any time from the study will not affect your ongoing relationship with Loma
Linda Health and will not involve any penalty or loss of benefits to which you are
otherwise entitled.
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8. What happens if I want to stop taking part in this study?
You are free to withdraw from this study at any time. If you decide to withdraw from this
study you should notify the research team immediately. The research team may also end
your participation in this study if you do not follow instructions, miss scheduled visits, or
if your safety and welfare are at risk.

9. How will information about me kep confidential?
Your identity will not be recorded with the research data. We cannot guarantee absolute
confidentiality. You will not be identified by name in any publications describing the
results of this study. All electronic data will be maintained on an encrypted computer and
paper data kept in a locked file cabinet in a locked office.

10. Will I be paid to participate in this study?
You will not be paid to participate in this research study but you will receive a $25 gift
card on each of the two days of data collection.

11. How do I call if I am injured as a result of being in this study?
If you feel you have been injured by taking part in this study, consult with a physician or
call 911 if the situation is a medical emergency. No funds have been set aside nor any
plans made to compensate you for time lost for work, disability, pain or other discomforts
resulting from your participation in this research.
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12. Who do I call if I have questions?
If you wish to contact an impartial third party not associated with this study regarding
any questions about your rights or to report a complaint you may have about the study,
you may contact the Office of Patient Relations, Loma Linda University Medical Center,
Loma Linda, CA 92354, phone (909) 558-4647, e-mail patientrelations@llu.edu for
information and assistance.

13. Subject’s statement of consent
I have read the contents of the consent form and have listened to the verbal explanation
given by the investigator. My questions concerning this study have been answered to my
satisfaction. Signing this consent document does not waive my rights nor does it release
the investigators, institution or sponsors from their responsibilities. I hereby give
voluntary consent to participate in this study.



I may call Eric Johnson during routine office hours at (909) 558-4632 extension
47471 or during non-office hours at (909) 658-5223 if I have additional questions or
concerns.

I understand I will be given a copy of this consent form after signing it.

Signature of Subject

Printed Name of Subject
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Date

14. Investigator’s statements
I have reviewed the contents of this consent form with the person signing above. I have
explained potential risks and benefits of the study.

Signature of Investigator

Printed Name of Investigator

Date
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APPENDIX D
AUTHORIZATION FOR USE OF PROTECTED HEALTH INFROMATION

Authorization for Use of
Protected Health Information (PHI)
Per 45 CFR §164.508(b)
RESEARCH PROTECTION PROGRAMS
LOMA LINDA UNIVERSITY | Office of the Vice President of Research Affairs
24887 Taylor Street, Suite 202 Loma Linda, CA 92350
(909) 558-4531 (voice) / (909) 558-0131 (fax)/e-mail: irb@llu.edu

Title of study:

PRINCIPAL
INVESTIGATOR:
Others who will use,
collect, or share PHI:

The Effect of Intraneural Facilitation on Balance in Patients
with Diabetic Peripheral Neuropathy
Eric G. Johnson, DSc, PT, MS-HPED, NCS
Adel Alshahrani
Shilpa Gaikwad
Mark Bussell

The study named above may be performed only by using personal information
relating to your health. National and international data protection regulations give you the
right to control the use of your medical information. Therefore, by signing this form, you
specifically authorize your medical information to be used or shared as described below.
The following personal information, considered “Protected Health Information”
(PHI) is needed to conduct this study and may include, but is not limited to name, birth
date, phone number, and e-mail.
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The individual(s) listed above will use or share this PHI in the course of this study
with the Institutional Review Board (IRB) and the Office of Research Affairs of Loma
Linda University.
The main reason for sharing this information is to be able to conduct the study as
described earlier in the consent form. In addition, it is shared to ensure that the study
meets legal, institutional, and accreditation standards. Information may also be shared to
report adverse events or situations that may help prevent placing other individuals at risk.
All reasonable efforts will be used to protect the confidentiality of your PHI,
which may be shared with others to support this study, to carry out their responsibilities,
to conduct public health reporting and to comply with the law as applicable. Those who
receive the PHI may share with others if they are required by law, and they may share it
with others who may not be required to follow national and international “protected
health information” (PHI) regulations such as the federal privacy rule.
Subject to any legal limitations, you have the right to access any protected health
information created during this study. You may request this information from the
Principal Investigator named above but it will only become available after the study
analyses are complete.


This authorization expires on August 15, 2015.
You may change your mind about this authorization at any time. If this happens, you

must withdraw your permission in writing. Beginning on the date you withdraw your
permission, no new personal health information will be used for this study. However, study
personnel may continue to use the health information that was provided before you
withdrew your permission. If you sign this form and enter the study, but later change your
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mind and withdraw your permission, you will be removed from the study at that time. To
withdraw your permission, please contact the Principal Investigator or study personnel at
909-558-4632 extension 47471.
You may refuse to sign this authorization. Refusing to sign will not affect the present
or future care you receive at this institution and will not cause any penalty or loss of benefits
to which you are entitled. However, if you do not sign this authorization form, you will
not be able to take part in the study for which you are being considered. You will receive
a copy of this signed and dated authorization prior to your participation in this study.

I agree that my personal health information may be used for the study purposes described
in this form.

Signature of Patient

Date

or Patient’s Legal Representative

Printed Name of Legal Representative

Representative’s Authority

(if any)

to Act for Patient

Signature of Investigator Obtaining

Date

Authorization
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